desipramine has been researched along with Drug Abuse, Intravenous in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hepburn, S | 1 |
| Harden, J | 1 |
| Grieve, JH | 1 |
| Hiscox, J | 1 |
| Tzschentke, TM | 1 |
| Magalas, Z | 1 |
| De Vry, J | 1 |
2 other studies available for desipramine and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Deliberate misuse of tricyclic antidepressants by intravenous drug users--case studies and report.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Cause of Death; Desipramine; Fem | 2005 |
Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Association Lea | 2006 |